{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:19:00Z","timestamp":1772165940414,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Luhe Hospital Youth Scientific Research Incubation Project","award":["LHYY2019-LC11"],"award-info":[{"award-number":["LHYY2019-LC11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Omega-3 polyunsaturated fatty acids (PUFAs) produce lipid mediators with both anti-inflammatory and pro-resolution properties, including resolvins. The purpose of this study was to detect serum resolvin E1 (RVE1) levels in Hashimoto\u2019s thyroiditis (HT) patients and healthy controls (HCs) and to evaluate the relationship of RVE1 with thyroid autoimmunity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 57 participants were recruited, including 30 untreated HT patients and 27 age- and sex\u2010matched HCs. The levels of RVE1 in serum were measured via enzyme-linked immunosorbent assay (ELISA). An electrochemiluminescence immunoassay was used for the measurement of thyroid-stimulating hormone (TSH), total T4 (TT4), TT3, free T4 (FT4), FT3, anti-thyroid peroxidase antibody (TPOAb) and anti-thyroglobulin antibody (TgAb) levels. Hemogram tests and routine biochemical analyses were performed on each sample.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The serum level of RVE1 of HT patients (24.09, 15.76\u201334.38 pg\/mL) was significantly lower than that of healthy controls (28.51, 20.76\u201351.23 pg\/mL) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027). RVE1 levels showed a downward trend with increasing TgAb levels (P for trend\u2009=\u20090.001). Multivariable ordinal logistic regression analysis showed that RVE1 levels were negatively correlated with increasing TgAb levels in both the unadjusted (OR\u2009=\u20090.9446, 95\u2009% CI\u2009=\u20090.9111\u20130.9782,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) and adjusted models (OR\u2009=\u20090.9380, 95\u2009% CI\u2009=\u20090.8967\u20130.9811,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Decreased RVE1 levels might be a sign that HT is associated with inflammatory resolution dysfunction. RVE1 may serve as a protective factor against increased TgAb levels.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-021-00730-9","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T12:35:31Z","timestamp":1618317331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Serum resolvin E1 levels and its relationship with thyroid autoimmunity in Hashimoto\u2019s thyroiditis: a preliminary study"],"prefix":"10.1186","volume":"21","author":[{"given":"Jing","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"issue":"4\u20135","key":"730_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4\u20135):391\u20136.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"730_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/thy.2019.0067","volume":"30","author":"Y Li","year":"2020","unstructured":"Li Y, Teng D, Ba J, Chen B, Du J, He L, Lai X, Teng X, Shi X, Li Y, et al. Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China. Thyroid. 2020;30(4):568\u201311.","journal-title":"Thyroid"},{"issue":"3","key":"730_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s12020-013-0121-x","volume":"46","author":"X Wu","year":"2014","unstructured":"Wu X, Lun Y, Jiang H, Gang Q, Xin S, Duan Z, Zhang J. Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer. Endocrine. 2014;46(3):554\u20136.","journal-title":"Endocrine"},{"key":"730_CR4","doi-asserted-by":"crossref","unstructured":"Xu W, Huo L, Chen Z, Huang Y, Jin X, Deng J, Zhu S, Yu Y. The Relationship of TPOAb and TGAb with Risk of Thyroid Nodules: A Large Epidemiological Study. Int J Environ Res Public Health. 2017; 14(7).","DOI":"10.3390\/ijerph14070723"},{"issue":"8","key":"730_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.kjms.2016.06.006","volume":"32","author":"H Bektas Uysal","year":"2016","unstructured":"Bektas Uysal H, Ayhan M. Autoimmunity affects health-related quality of life in patients with Hashimoto\u2019s thyroiditis. Kaohsiung J Med Sci. 2016;32(8):427\u20136.","journal-title":"Kaohsiung J Med Sci"},{"issue":"7","key":"730_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.4158\/EP161635.RA","volume":"23","author":"G Chiarella","year":"2017","unstructured":"Chiarella G, Russo D, Monzani F, Petrolo C, Fattori B, Pasqualetti G, Cassandro E, Costante G. Hashimoto Thyroiditis and Vestibular Dysfunction. Endocr Pract. 2017;23(7):863\u20138.","journal-title":"Endocr Pract"},{"issue":"5","key":"730_CR7","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/thy.2016.0635","volume":"27","author":"S Hu","year":"2017","unstructured":"Hu S, Rayman MP. Multiple Nutritional Factors and the Risk of Hashimoto\u2019s Thyroiditis. Thyroid. 2017;27(5):597\u20133.","journal-title":"Thyroid"},{"issue":"1","key":"730_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1017\/S0029665118001192","volume":"78","author":"MP Rayman","year":"2019","unstructured":"Rayman MP. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc Nutr Soc. 2019;78(1):34\u201310.","journal-title":"Proc Nutr Soc"},{"issue":"12","key":"730_CR9","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1089\/thy.2016.0256","volume":"26","author":"J Wichman","year":"2016","unstructured":"Wichman J, Winther KH, Bonnema SJ, Hegedus L. Selenium Supplementation Significantly Reduces Thyroid Autoantibody Levels in Patients with Chronic Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis. Thyroid. 2016;26(12):1681\u201311.","journal-title":"Thyroid"},{"issue":"2","key":"730_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/BJ20110327","volume":"437","author":"G Fredman","year":"2011","unstructured":"Fredman G, Serhan CN. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J. 2011;437(2):185\u201312.","journal-title":"Biochem J"},{"issue":"5","key":"730_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349\u201312.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"730_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd.2016.39","volume":"15","author":"JN Fullerton","year":"2016","unstructured":"Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016;15(8):551\u201316.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"730_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","volume":"16","author":"MC Basil","year":"2016","unstructured":"Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016;16(1):51\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"730_CR14","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/bph.14587","volume":"176","author":"DW Gilroy","year":"2019","unstructured":"Gilroy DW, Bishop-Bailey D. Lipid mediators in immune regulation and resolution. Br J Pharmacol. 2019;176(8):1009\u201314.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"730_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.20042031","volume":"201","author":"M Arita","year":"2005","unstructured":"Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med. 2005;201(5):713\u20139.","journal-title":"J Exp Med"},{"key":"730_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3389\/fimmu.2018.01300","volume":"9","author":"K El Kholy","year":"2018","unstructured":"El Kholy K, Freire M, Chen T, Van Dyke TE. Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions. Front Immunol. 2018;9:1300.","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"730_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2012.12.003","volume":"256","author":"K Unoda","year":"2013","unstructured":"Unoda K, Doi Y, Nakajima H, Yamane K, Hosokawa T, Ishida S, Kimura F, Hanafusa T. Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol. 2013;256(1\u20132):7\u20135.","journal-title":"J Neuroimmunol"},{"key":"730_CR18","doi-asserted-by":"crossref","unstructured":"AlAmmar WA, Albeesh FH, Ibrahim LM, Algindan YY, Yamani LZ, Khattab RY. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci. 2019:1\u201310.","DOI":"10.1080\/1028415X.2019.1659560"},{"key":"730_CR19","doi-asserted-by":"crossref","unstructured":"Cadario F, Pozzi E, Rizzollo S, Stracuzzi M, Beux S, Giorgis A, Carrera D, Fullin F, Riso S, Rizzo AM, et al. Vitamin D and omega-3 Supplementations in Mediterranean Diet During the 1st Year of Overt Type 1 Diabetes: A Cohort Study. Nutrients. 2019; 11(9).","DOI":"10.3390\/nu11092158"},{"issue":"5","key":"730_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1172\/JCI87388","volume":"127","author":"X Bi","year":"2017","unstructured":"Bi X, Li F, Liu S, Jin Y, Zhang X, Yang T, Dai Y, Li X, Zhao AZ. omega-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity. J Clin Invest. 2017;127(5):1757\u201314.","journal-title":"J Clin Invest"},{"issue":"3","key":"730_CR21","first-page":"56","volume":"24","author":"K Dolan","year":"2018","unstructured":"Dolan K, Finley H, Gasta M, Houseman S. Managing Hashimoto\u2019s Thyroiditis Through Personalized Care: A Case Report. Altern Ther Health Med. 2018;24(3):56\u201361.","journal-title":"Altern Ther Health Med"},{"key":"730_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","volume":"25","author":"CN Serhan","year":"2007","unstructured":"Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101\u201336.","journal-title":"Annu Rev Immunol"},{"issue":"7146","key":"730_CR23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nature05877","volume":"447","author":"JM Schwab","year":"2007","unstructured":"Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447(7146):869\u20135.","journal-title":"Nature"},{"issue":"3","key":"730_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.molmed.2019.01.006","volume":"25","author":"KT Feehan","year":"2019","unstructured":"Feehan KT, Gilroy DW. Is Resolution the End of Inflammation? Trends Mol Med. 2019;25(3):198\u201316.","journal-title":"Trends Mol Med"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3389\/fimmu.2019.02241","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, Bi X, Wang S, Zhang Z, Li F, Zhao AZ. Therapeutic Potential of omega-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases. Front Immunol. 2019;10:2241.","journal-title":"Front Immunol"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.plefa.2016.03.004","volume":"107","author":"AE Barden","year":"2016","unstructured":"Barden AE, Moghaddami M, Mas E, Phillips M, Cleland LG, Mori TA. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;107:24\u20135.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"730_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00281-019-00767-y","volume":"41","author":"M Carracedo","year":"2019","unstructured":"Carracedo M, Artiach G, Arnardottir H, Back M. The resolution of inflammation through omega-3 fatty acids in atherosclerosis, intimal hyperplasia, and vascular calcification. Semin Immunopathol. 2019;41(6):757\u20139.","journal-title":"Semin Immunopathol"},{"key":"730_CR28","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3389\/fimmu.2017.01682","volume":"8","author":"MG Balta","year":"2017","unstructured":"Balta MG, Loos BG, Nicu EA. Emerging Concepts in the Resolution of Periodontal Inflammation: A Role for Resolvin E1. Front Immunol. 2017;8:1682.","journal-title":"Front Immunol"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.aca.2020.04.064","volume":"1120","author":"F Xia","year":"2020","unstructured":"Xia F, He C, Ren M, Xu FG, Wan JB. Quantitative profiling of eicosanoids derived from n-6 and n-3 polyunsaturated fatty acids by twin derivatization strategy combined with LC-MS\/MS in patients with type 2 diabetes mellitus. Anal Chim Acta. 2020;1120:24\u201311.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"730_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1096\/fj.05-4724fje","volume":"20","author":"H Hasturk","year":"2006","unstructured":"Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van Dyke TE. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. FASEB J. 2006;20(2):401\u20132.","journal-title":"FASEB J"},{"issue":"7","key":"730_CR31","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.4049\/jimmunol.1600859","volume":"197","author":"CT Lee","year":"2016","unstructured":"Lee CT, Teles R, Kantarci A, Chen T, McCafferty J, Starr JR, Brito LC, Paster BJ, Van Dyke TE. Resolvin E1 Reverses Experimental Periodontitis and Dysbiosis. J Immunol. 2016;197(7):2796\u201310.","journal-title":"J Immunol"},{"issue":"9","key":"730_CR32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.joen.2019.05.005","volume":"45","author":"H Xu","year":"2019","unstructured":"Xu H, Chen J, Ge J, Xia K, Tao S, Su Y, Zhang Q. Resolvin E1 Ameliorates Pulpitis by Suppressing Dental Pulp Fibroblast Activation in a Chemerin Receptor 23-dependent Manner. J Endod. 2019;45(9):1126\u20138.","journal-title":"J Endod"},{"issue":"3","key":"730_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/1119-3077.86763","volume":"14","author":"BS Patil","year":"2011","unstructured":"Patil BS, Patil S, Gururaj TR. Probable autoimmune causal relationship between periodontitis and Hashimotos thyroidits: a systemic review. Niger J Clin Pract. 2011;14(3):253\u20138.","journal-title":"Niger J Clin Pract"},{"issue":"2","key":"730_CR34","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1080\/08923973.2019.1584903","volume":"41","author":"A Siddiquee","year":"2019","unstructured":"Siddiquee A, Patel M, Rajalingam S, Narke D, Kurade M, Ponnoth DS. Effect of omega-3 fatty acid supplementation on resolvin (RvE1)-mediated suppression of inflammation in a mouse model of asthma. Immunopharmacol Immunotoxicol. 2019;41(2):250\u20137.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"730_CR35","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nm.2123","volume":"16","author":"ZZ Xu","year":"2010","unstructured":"Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, Serhan CN, Ji RR. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med. 2010;16(5):592\u20135.","journal-title":"Nat Med"},{"issue":"5","key":"730_CR36","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","volume":"35","author":"H Hasturk","year":"2015","unstructured":"Hasturk H, Abdallah R, Kantarci A, Nguyen D, Giordano N, Hamilton J, Van Dyke TE. Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis. Arterioscler Thromb Vasc Biol. 2015;35(5):1123\u201310.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"730_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0029-1241825","volume":"118","author":"T Lund","year":"2010","unstructured":"Lund T, Mangsbo SM, Scholz H, Gjorstrup P, Totterman TH, Korsgren O, Foss A. Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro. Exp Clin Endocrinol Diabetes. 2010;118(4):237\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-021-00730-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00730-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T12:36:43Z","timestamp":1618317403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00730-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00730-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-80993\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"20 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Beijing Luhe Hospital. After completely explaining the nature and purpose of all procedures utilized, informed written consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author reports no conflicts of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}